UPHEALTH INC (UPH) Fundamental Analysis & Valuation

NYSE:UPH • US91532B2007

Current stock price

0.3 USD
+0.03 (+9.13%)
Last:

This UPH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. UPH Profitability Analysis

1.1 Basic Checks

  • UPH had negative earnings in the past year.
  • UPH had a negative operating cash flow in the past year.
UPH Yearly Net Income VS EBIT VS OCF VS FCFUPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -100M -200M -300M

1.2 Ratios

  • UPH has a Return On Assets (-31.98%) which is comparable to the rest of the industry.
  • UPH has a Return On Equity of -117.29%. This is in the lower half of the industry: UPH underperforms 62.79% of its industry peers.
  • UPH has a better Return On Invested Capital (1.59%) than 86.05% of its industry peers.
Industry RankSector Rank
ROA -31.98%
ROE -117.29%
ROIC 1.59%
ROA(3y)-42.12%
ROA(5y)N/A
ROE(3y)-106.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UPH Yearly ROA, ROE, ROICUPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -50 -100 -150 -200

1.3 Margins

  • With an excellent Operating Margin value of 0.90%, UPH belongs to the best of the industry, outperforming 81.40% of the companies in the same industry.
  • With a Gross Margin value of 45.52%, UPH is not doing good in the industry: 60.47% of the companies in the same industry are doing better.
Industry RankSector Rank
OM 0.9%
PM (TTM) N/A
GM 45.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UPH Yearly Profit, Operating, Gross MarginsUPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -100 -200

1

2. UPH Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so UPH is destroying value.
  • UPH has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for UPH is higher compared to a year ago.
UPH Yearly Shares OutstandingUPH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 5M 10M 15M 20M
UPH Yearly Total Debt VS Total AssetsUPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

  • UPH has an Altman-Z score of -3.70. This is a bad value and indicates that UPH is not financially healthy and even has some risk of bankruptcy.
  • UPH's Altman-Z score of -3.70 is on the low side compared to the rest of the industry. UPH is outperformed by 67.44% of its industry peers.
  • UPH has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.03, UPH is doing good in the industry, outperforming 69.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -3.7
ROIC/WACC0.24
WACC6.53%
UPH Yearly LT Debt VS Equity VS FCFUPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 100M 200M 300M

2.3 Liquidity

  • UPH has a Current Ratio of 0.13. This is a bad value and indicates that UPH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.13, UPH is doing worse than 97.67% of the companies in the same industry.
  • A Quick Ratio of 0.13 indicates that UPH may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.13, UPH is not doing good in the industry: 97.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
UPH Yearly Current Assets VS Current LiabilitesUPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 20M 40M 60M 80M 100M

2

3. UPH Growth Analysis

3.1 Past

  • UPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.97%, which is quite impressive.
  • UPH shows a small growth in Revenue. In the last year, the Revenue has grown by 3.24%.
EPS 1Y (TTM)34.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
Revenue 1Y (TTM)3.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.49%

3.2 Future

  • UPH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.89% yearly.
  • UPH is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.68% yearly.
EPS Next Y72.87%
EPS Next 2Y40.69%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue Next Year-7.87%
Revenue Next 2Y-37.26%
Revenue Next 3Y-0.68%
Revenue Next 5YN/A

3.3 Evolution

UPH Yearly Revenue VS EstimatesUPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 50M 100M 150M
UPH Yearly EPS VS EstimatesUPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -5 -10

1

4. UPH Valuation Analysis

4.1 Price/Earnings Ratio

  • UPH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UPH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UPH Price Earnings VS Forward Price EarningsUPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UPH is valued cheaper than 90.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.37
UPH Per share dataUPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

  • UPH's earnings are expected to grow with 23.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.69%
EPS Next 3Y23.89%

0

5. UPH Dividend Analysis

5.1 Amount

  • No dividends for UPH!.
Industry RankSector Rank
Dividend Yield N/A

UPH Fundamentals: All Metrics, Ratios and Statistics

UPHEALTH INC

NYSE:UPH (12/11/2023, 8:20:46 PM)

0.3

+0.03 (+9.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-20
Earnings (Next)02-29
Inst Owners0.11%
Inst Owner Change61211.9%
Ins Owners112.9%
Ins Owner Change0%
Market Cap5.33M
Revenue(TTM)153.15M
Net Income(TTM)-75.18M
Analysts82.5
Price Target5.24 (1646.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-362.92%
Min EPS beat(2)-624.95%
Max EPS beat(2)-100.89%
EPS beat(4)1
Avg EPS beat(4)-206.44%
Min EPS beat(4)-624.95%
Max EPS beat(4)19.85%
EPS beat(8)3
Avg EPS beat(8)-213.41%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)14.44%
Min Revenue beat(2)13.83%
Max Revenue beat(2)15.05%
Revenue beat(4)4
Avg Revenue beat(4)11.19%
Min Revenue beat(4)0.81%
Max Revenue beat(4)15.06%
Revenue beat(8)4
Avg Revenue beat(8)2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.55%
PT rev (3m)-14.55%
EPS NQ rev (1m)43.5%
EPS NQ rev (3m)43.5%
EPS NY rev (1m)-11.26%
EPS NY rev (3m)-11.26%
Revenue NQ rev (1m)12.58%
Revenue NQ rev (3m)112482%
Revenue NY rev (1m)5.99%
Revenue NY rev (3m)5.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.08
P/tB N/A
EV/EBITDA 10.37
EPS(TTM)-7.7
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-1.31
OCFYN/A
SpS8.61
BVpS3.61
TBVpS-2.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.98%
ROE -117.29%
ROCE 2.01%
ROIC 1.59%
ROICexc 1.67%
ROICexgc N/A
OM 0.9%
PM (TTM) N/A
GM 45.52%
FCFM N/A
ROA(3y)-42.12%
ROA(5y)N/A
ROE(3y)-106.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.12
Cap/Depr 37.34%
Cap/Sales 3.21%
Interest Coverage 0.09
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z -3.7
F-Score5
WACC6.53%
ROIC/WACC0.24
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
EPS Next Y72.87%
EPS Next 2Y40.69%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue 1Y (TTM)3.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.49%
Revenue Next Year-7.87%
Revenue Next 2Y-37.26%
Revenue Next 3Y-0.68%
Revenue Next 5YN/A
EBIT growth 1Y102.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.28%
EBIT Next 3Y43.77%
EBIT Next 5YN/A
FCF growth 1Y45.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.9%
OCF growth 3YN/A
OCF growth 5YN/A

UPHEALTH INC / UPH Fundamental Analysis FAQ

What is the ChartMill fundamental rating of UPHEALTH INC (UPH) stock?

ChartMill assigns a fundamental rating of 1 / 10 to UPH.


What is the valuation status of UPHEALTH INC (UPH) stock?

ChartMill assigns a valuation rating of 1 / 10 to UPHEALTH INC (UPH). This can be considered as Overvalued.


What is the profitability of UPH stock?

UPHEALTH INC (UPH) has a profitability rating of 2 / 10.


What is the financial health of UPHEALTH INC (UPH) stock?

The financial health rating of UPHEALTH INC (UPH) is 1 / 10.